Evaluating the Effectiveness of Intranasal Butorphanol in Reducing Chronic Itch
Acta Derm Venereol
.
2022 Jun 9:102:adv00729.
doi: 10.2340/actadv.v102.2153.
Authors
Angelina Labib
,
Teresa Ju
,
Zoe Morgan Lipman
,
Gil Yosipovitch
1
Affiliation
1
Dr Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, 1600 NW 10th Ave RMSB Building 2067B, Miami, FL, USA. gyosipovitch@med.miami.edu.
PMID:
35470402
PMCID:
PMC9574675
DOI:
10.2340/actadv.v102.2153
No abstract available
MeSH terms
Administration, Intranasal
Analgesics, Opioid / adverse effects
Butorphanol* / adverse effects
Humans
Pruritus* / diagnosis
Pruritus* / drug therapy
Substances
Analgesics, Opioid
Butorphanol